Coredio

CoreDio offers a non-invasive platform for wearable based advanced monitoring, allowing point-of-care medication management for heart failure and other cardiac diseases.

Based based in Silicon Valley, California, Coredio works in health.

Profile

"CoreDio Corp is a pioneering company in the fields of Artificial Intelligence, Health, and Mobility, offering a revolutionary non-invasive platform for enhanced cardiovascular monitoring. By developing a patent-protected solution to measure patient-specific Central Blood Pressure (CBP) and Cardiac Output (CO) data, CoreDio aims to transform heart failure diagnosis and care. With cardiovascular disorders being a leading cause of mortality globally, early detection of heart failure is crucial. Current diagnostic methods like cardiac catheterization and transthoracic echo are invasive and costly. CoreDio's platform fills a critical gap by providing consistent, non-invasive, and individualized measurements of CBP and CO. Led by a team of experts with diverse backgrounds in medical device development, physiological algorithms, and product design, CoreDio is on a mission to shape its innovative solution into a user-friendly SaaS platform. Collaborations with leading hospitals and a clear FDA pathway demonstrate the company's commitment to advancing cardiovascular healthcare."

The company sits in the health segment, where it competes on its core product or service.

Its base of operations is Silicon Valley, California.

It is recorded at the Plug and Play accelerated startup stage.

Website: www.coredio-ai.com